Publications

5808 Results

Impact of body mass index and weight change after teatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. [PMC2654367; PMID18757324]

Authors
JA Meyerhardt;D Niedzwiecki;D Hollis;LB Saltz;RJ Mayer;H Nelson;R Whittom;A Hantel;J Thomas;J Thomas;C Fuchs
Journal / Conference
Journal of Clinical Oncology 26(25):4109-4115
Year
2008
Research Committee(s)
Gastrointestinal
Study Number(s)
C89803

Recommendations for collection and handling of specimens from group breast cancer clinical trials, from onsite collection through shipping to the central bank [PMC2651095; PMID18955459]

Authors
B Leyland-Jones;CB Ambrosone;M Ellis;R Enos;A Raji;M Pins;JA Zujewski;J Bartlett;S Hewitt;J Forbes;S Jewell
Journal / Conference
Journal of Clinical Oncology 26(34):5638-5644
Year
2008
Research Committee(s)
Breast and Molecular Epidemiology

MUM1 expression in follicular lymphoma is a poor prognostic marker in patients treated with immunochemotherapy (SWOG 9800/9911) but not chemotherapy alone (SWOG 8809): A Southwest Oncology Group correlative science study

Authors
ED Hsi;B Goldman;LM Rimsza;JR Cook;RR Tubbs;OW Press;DG Maloney;RI Fisher;JW Sweetenham
Journal / Conference
Blood 112(11):146, abst. 376
Year
2008
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8809, S9800, S9911

Effect of rituximab on residence time of I-131 tositumomab consolidation therapy in patients (pts) with non-Hodgkin's lymphoma (NHL): analysis of SWOG clinical trials

Authors
J Schaefer-Cutillo;V Chengazi;D Peterson;D Maloney;K Kibler;EM Cebula;S Bernstein;F Young;O Press;LM Rimsza;RI Fisher;JW Friedberg
Journal / Conference
Blood 112(11):697-698, Abst. #2000
Year
2008
Research Committee(s)
Lymphoma
Study Number(s)
S0016, S0433

Multiplexed AQUA-based assessment of SWOG 9313 shows prognostic value of continuous variable assessment

Authors
DL Rimm;M Harigopal;G Tedeschi;PL Porter;I-T Yeh;CM Haskell;W Barlow;RB Livingston;GN Hortobagyi;DF Hayes
Journal / Conference
San Antonio Breast Cancer Symposium, abstract #75
Year
2008
Research Committee(s)
Breast
Study Number(s)
SWOG-9313

Effect of adding ibritumomab tiuxetan (Zevalin) radioimmunotherapy consolidation to three cycles of CHOP plus involved-field radiotherapy for high risk limited stage aggressive diffuse B-cell lymphoma (Southwest Oncology Group Study 0313)

Authors
TP Miller;JM Unger;CM Spier;B Stea;OW Press;M LeBlanc;RI Fisher
Journal / Conference
Blood 112(11):1231, abst. #3598
Year
2008
Research Committee(s)
Lymphoma
Study Number(s)
S0313

Results of the p53 targeted therapy trial for patients with organ confined node negative bladder cancer treated with radical cystectomy

Authors
SP Lerner;JP Stein;E Tuazon;DG Skinner;D Raghavan;D Esrig;WM Stadler;S Groshen;G Steinberg;R Cote;C Hall
Journal / Conference
Society of Urologic Oncology 2008 Annual Meeting (oral presentation)
Year
2008
Research Committee(s)
Genitourinary
Study Number(s)
4B951

Updated results of SWOG 8794: adjuvant radiation for high risk prostate cancer

Authors
GP Swanson;IM Thompson;CM Tangen;JC Paradelo;ED Canby-Hagino;ED Crawford;MS Lucia;JD Forman;JL Chin;EM Messing
Journal / Conference
Radiotherapy and Oncology 88(S2):S148(449)
Year
2008
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8794

Prognostic significance of pathologic SV involvement and the effect of adjuvant radiation therapy on outcome

Authors
GP Swanson;IM Thompson;B Goldman;CM Tangen;JL Chin;EM Messing;ED Canby-Hagino;JD Forman;ED Crawford
Journal / Conference
Radiotherapy and Oncology 88(S2):S337(1057)
Year
2008
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8794

Update of SWOG 8794: adjuvant radiotherapy of pT3 prostate cancer improves metastasis free survival

Authors
GP Swanson;IM Thompson;CM Tangen;JC Paradelo;ED Canby-Hagino;ED Crawford;GJ Miller;MS Lucia;JD Forman;JL Chin
Journal / Conference
International Journal of Radiation Oncology Biology Physics 72(1)suppl. 1:S31
Year
2008
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8794